Effective components of Panax quinquefolius and Corydalis tuber protect the myocardium by inhibiting platelet activation and improving the hypercoagulable state

Xue,Mei; Liu,Mei‑Lin; Zhu,Xin‑Yuan; Shi,Da‑Zhuo; Yin,Hui‑Jun

doi:10.3892/etm.2015.2271

Effective components of Panax quinquefolius and Corydalis tuber protect the myocardium by inhibiting platelet activation and improving the hypercoagulable state

Authors:
- Mei Xue
- Mei‑Lin Liu
- Xin‑Yuan Zhu
- Da‑Zhuo Shi
- Hui‑Jun Yin
View Affiliations

Affiliations: Cardiovascular Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Haidian, Beijing 100091, P.R. China, Department of Geriatric Medicine, Peking University First Hospital, Beijing 100034, P.R. China
Published online on: February 6, 2015 https://doi.org/10.3892/etm.2015.2271
Pages: 1477-1481

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of extract of Panax quinquefolius and Corydalis tuber (EPC) on platelet activation and the hypercoagulable state in rats with acute myocardial infarction (AMI). The MI model in Wistar rats was induced by coronary artery ligation. Sham surgery was performed as a control. The surviving rats that underwent MI surgery were divided into control (administered normal saline), metoprolol (9 mg/kg) and low‑, moderate‑ and high‑dose EPC groups (0.54, 1.08 g/kg and 2.16 g/kg, respectively). Saline, metoprolol and EPC were administered by gastrogavage for two consecutive weeks. The morphological changes of the myocardium were assessed by hematoxylin and eosin and nitroblue tetrazolium staining. Serum von Willebrand factor (vWF), D‑dimer (DD), platelet membrane glycoproteins IIb‑IIIa (GPIIb‑IIIa) and CD62P levels were assessed using enzyme‑linked immunosorbent assay. EPC attenuated the pathological changes of the myocardium. High‑dose EPC decreased the serum concentration of vWF when compared with control group. Moderate and high doses of EPC decreased the DD and GPIIb‑IIIa levels, and the CD62P level was gradually decreased with EPC dose escalation. The results therefore demonstrated that EPC protects the myocardium by inhibiting platelet activation and improving the hypercoagulable state in a rat model of AMI.

View Figures

View References

1	Xue M, Liu ML, Zhu XY, et al: Effective components of Panax quinquefolius and Corydalis tuber protect myocardium through attenuating oxidative stress and endoplasmic reticulum stress. Evid Based Complement Alternat Med. 2013:4823182013. View Article : Google Scholar : PubMed/NCBI
2	Zhang XR, Zhao YL, Wang JB, et al: Differences between cold and hot natures of processed Radix ginseng rubra and Panax quinquefolius L. based upon mice temperature tropism. Zhonghua Yi Xue Za Zhi. 89:1994–1998. 2009.(In Chinese). PubMed/NCBI
3	People’s Republic of China Pharmacopoeia Commission, . Pharmacopoeia of the People’s Republic of China. Chemical Industry Press; Beijing, China: 2000
4	Zhu XY, Zhang ZL, Li P, et al: Shenyuan, an extract of American Ginseng and Corydalis Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and oxidative stress in a porcine model of acute myocardial infarction. J Ethnopharmacol. 150:672–681. 2013. View Article : Google Scholar : PubMed/NCBI
5	Abe S, Maruyama I, Arima S, et al: Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system. Int J Cardiol. 47:S7–12. 1994. View Article : Google Scholar : PubMed/NCBI
6	Liu YM, Zhang J, Shi F, et al: Studies on extracting methods of shenyuan tablet (effective components of American Ginseng and Corydalis tuber).). Zhong Guo Shi Yan Fang Ji Xue Za Zhi. 17:18–21. 2012.(In Chinese).
7	Abbate A, Salloum FN, Vecile E, et al: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 117:2670–2683. 2008. View Article : Google Scholar : PubMed/NCBI
8	Olivetti G, Capasso JM, Meggs LG, et al: Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 68:856–869. 1991. View Article : Google Scholar : PubMed/NCBI
9	Xue M, Yin HJ, Zhang L, et al: Dynamic expression of the main related indicators to thrombosis, inflammation reaction and tissue damage in a rat model of myocardial infarction. Mol Med Rep. 4:693–696. 2011.PubMed/NCBI
10	Whincup PH, Danesh J, Walker M, et al: von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 23:1764–1770. 2002. View Article : Google Scholar : PubMed/NCBI
11	Wang Y, Andrews M, Yang Y, et al: Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets. 12:126–132. 2012. View Article : Google Scholar : PubMed/NCBI
12	Xue M, Yin HJ, Wu CF, Ma XJ, et al: Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome. Chin J Integr Med. 19:42–47. 2013. View Article : Google Scholar
13	Xue M, Zhang L, Yang L, et al: Effect of Chinese herbal medicine for activating blood circulation and detoxifying on expression of inflammatory reaction and tissue damage related factors in experimental carotid artery thrombosis rats. Chin J Integr Med. 16:247–251. 2010. View Article : Google Scholar : PubMed/NCBI
14	Chen KJ, Xue M and Yin HJ: The relationship between platelet activation and coronary heart disease and blood-stasis syndrome. Shou Du Yi Ke Da Xue Xue Bao. 29(29): 266–269. 2008.(In Chinese).
15	Bledzka K, Smyth SS and Plow EF: Integrin αIIbβ3: from discovery to efficacious therapeutic target. Circ Res. 112:1189–1200. 2013. View Article : Google Scholar : PubMed/NCBI
16	Andrews RK and Berndt MC: Platelet physiology and thrombosis. Thromb Res. 114:447–453. 2004. View Article : Google Scholar : PubMed/NCBI
17	Szántó T, Joutsi-Korhonen L, Deckmyn H, et al: New insights into von Willebrand disease and platelet function. Semin Thromb Hemost. 38:55–63. 2012. View Article : Google Scholar : PubMed/NCBI
18	Danesh J, Whincup P, Walker M, et al: Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 103:2323–2327. 2001. View Article : Google Scholar : PubMed/NCBI
19	Yang J and Li CS: The predictive values of D-dimer for the early prognosis of the acute myocardial infarction (AMI): a review of 3134 AMI patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 24:725–729. 2012.(In Chinese). PubMed/NCBI
20	Yang L, Miao Y, YIN HJ, et al: Identification of ginsenosides from Panax quinquefolius in Xinyue Capsule by LC-ESI-MSn. Zhong Cao Yao. 41:1942–1947. 2010.(In Chinese).
21	Sun S, Chen Z, Li L, et al: The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica. 42:1197–1205. 2012. View Article : Google Scholar : PubMed/NCBI
22	Ibanez B, Fuster V, Macaya C, et al: Study design for the ‘effect of METOprolol in CARDioproteCtioN during an acutemyocardial infarction’ (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am Heart J. 164:473–480. 2012. View Article : Google Scholar
23	Wu A, Zhai J, Zhang D, et al: Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction. Evid Based Complement Alternat Med. 2013:9679862013. View Article : Google Scholar : PubMed/NCBI